TrialPloS one2016

Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.

Heiner Wedemeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.